First Church of Christ Congregational
- (Directions)
2183 Main Street
Glastonbury, CT
Meets: Fourth Thursday of each month, 7 PM
Sponsored by Hartford Hospital, this group is open to transplant recipients and their families, as well as patients awaiting transplantation, this group provides educational, social, and other supportive services. Contact John McNab or Colleen Brown for more information.
Contact John McNab (Hartford Hospital) for more information.
Phone: 860-545-2142
Hepatitis and Liver Disease Support Groups
ALF Office - (Directions)
127 Washington Ave 2nd Floor
North Haven, CT 06473
Meets: 6:30 PM
The Connecticut Division has formed a new support group for Hepatitis C patients which will be available to those with this condition and/or undergoing therapy for same and for the general public who woud likei nformation on liver diseases.
Kathryn Jack, MSN, FNP-BC, Associate Medical Advisory Chairman (AMAC) for the Division, will be serving as the main facilitator along with Julie Burns, Genentech and Jeannine Hampton, ARPN of the Associate Medical Advisory Committee.
The groups will be meeting at the Division office, 127 Washington Avenue, North Haven on the first Thursday of every month. If you are interested in attending this support group please call the Division office for further information. (203)234-2022 or email pscarfo@liverfoundation.org
Contact Phil Scarfo, Program Manager for more information.
Phone: 203-234-2022
Email: Hepatitis and Liver Disease Support Groups
Boceprevir and Peginterferon/Ribavirin for the Treatment of Chronic
Trial Name: Boceprevir and Peginterferon/Ribavirin for the Treatment of Chronic
Hepatitis C in Treatment-Naive Subjects: A Comparison of Erythropoietin Use Versus Ribavirin Dose Reduction for the
Management of Anemia (Protocol No. P06086)
Summary: This is a randomized, multi-center, parallel-arm, open-label trial to compare two strategies for the
management of anemia (erythropoietin use versus RBV dose reduction) in subjects with previously untreated
CHC (genotype 1) who become anemic during therapy with boceprevir plus PEG2b/RBV, to be conducted in
conformance with Good Clinical Practice (GCP). Adult subjects infected with chronic HCV genotype 1 with no previous
treatment for CHC will be selected to participate in the trial.
Sponsored by: Schering-Plough Research Institute, a Division of Schering Corporation
Principal Investigator: George Wu, M.D., Ph.D.
Contact: Chidinma Byron, APRN for more information
Phone: 860-679-4260
Contact Chidinma Byron, APRN for more information.
Phone: 860-679-4260
Hong Chau, M.P.H.
Phase 2 Multicenter, Randomizes, Open-Label, Dose-Ranging Study of Interferon-Alfa 2b Given Via Continuous Subcutaneous Infusion in Subjects with Genotype 1 Hepatitis C Virus Infection
Sponsor: Medtronic
Principal Investigator: Joseph K. Lim, M.D.
Contact: Hong Chau, M.P.H.
Ph #: (203) 785-3409
Phone: (203) 785-3409
Hong Chau, M.P.H.
Randomized Controlled Phase 2b Study of the Efficacy and Safety of PEG-rIL-29 Administered in Combination with Ribavirin to Treatment-Naive Subjects with Chronic Hepatitis C Infection
Sponsor: Zymogenetics/BMS
Principal Investigator: Joseph K. Lim, M.D.
Contact: Hong Chau, M.P.H.
Ph #: (203) 785-3409
Phone: (203) 785-3409
Transplant Experience News
Web: www.transplantexperience.com
Coalition on Donation - Donate Life
Web: www.donatelife.net
Transplant Patients
First Church of Christ Congregational - (Directions)
2183 Main Street
Glastonbury, CT
Open to transplant recipients and their families, as well as patients awaiting transplantation, this group provides education, social and other supportive services. Sponsored by Hartford Hospital, the group meets on the fourth Thursday of each month at 7 PM. Contact John McNab or Colleen Brown for more information.
Phone: 860-545-2142
American Liver Foundation
Web: www.liverfoundation.org
Caringbridge Organization
Caringbridge Organization is a nonprofit that offers free, personalized web sites to families and friends who wish to be connected during a time of need.
Web: www.caringbridge.org
Liver Disease -- Hepatitis Magazine
Web: www.hepatitismag.com
Print
del.icio.us